iShares Biotechnology ETF $IBB Shares Sold by Militia Capital Partners LP

Militia Capital Partners LP lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 34.5% in the fourth quarter, HoldingsChannel reports. The firm owned 10,800 shares of the financial services provider’s stock after selling 5,700 shares during the quarter. Militia Capital Partners LP’s holdings in iShares Biotechnology ETF were worth $1,823,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in IBB. Brighton Jones LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter valued at approximately $201,000. AQR Capital Management LLC acquired a new position in iShares Biotechnology ETF during the 1st quarter valued at approximately $455,000. Millennium Management LLC boosted its position in iShares Biotechnology ETF by 140.8% during the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock valued at $5,330,000 after purchasing an additional 143,893 shares during the period. M&T Bank Corp boosted its position in iShares Biotechnology ETF by 39.3% during the 2nd quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock valued at $337,000 after purchasing an additional 750 shares during the period. Finally, Walleye Capital LLC boosted its position in iShares Biotechnology ETF by 26.8% during the 2nd quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock valued at $589,000 after purchasing an additional 985 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $171.44 on Wednesday. iShares Biotechnology ETF has a 12-month low of $123.61 and a 12-month high of $179.64. The business has a 50 day simple moving average of $170.38 and a 200 day simple moving average of $170.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Monday, June 15th will be given a dividend of $0.0238 per share. The ex-dividend date is Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.